Shengxian Yuan

4PUBLICATIONS
43CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 05, 2024
Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target.

Dong-Yang Ding, Shu-Ya Jiang, Yun-Xi Zu

|Mar 27, 2024
Paradoxical Activation of Oncogenic Signaling as a Cancer Treatment Strategy.

Matheus Henrique Dias, Anoek Friskes, Siying Wang

|Dec 16, 2022
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinoma.

Dong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang

|May 09, 2022
DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334.

Dapeng Sun, Xiaojie Gan, Lei Liu

Pageof 1

Frequent Collaborators

3 joint publications

Weiping Zhou

2 joint publications

Fu Yang

1 joint publications

Lei Liu

1 joint publications

Xiao-Jie Gan